Chapel Dental Laboratory Limited 12766946 false 2025-08-01 2026-03-31 2026-03-31 The principal activity of the company is manufacture of dental products Digita Accounts Production Advanced 6.30.9574.0 true true 12766946 2025-08-01 2026-03-31 12766946 2026-03-31 12766946 bus:OrdinaryShareClass1 2026-03-31 12766946 bus:OrdinaryShareClass2 2026-03-31 12766946 bus:OrdinaryShareClass3 2026-03-31 12766946 bus:OrdinaryShareClass4 2026-03-31 12766946 core:CurrentFinancialInstruments 2026-03-31 12766946 core:CurrentFinancialInstruments core:WithinOneYear 2026-03-31 12766946 core:FurnitureFittingsToolsEquipment 2026-03-31 12766946 core:MotorVehicles 2026-03-31 12766946 bus:SmallEntities 2025-08-01 2026-03-31 12766946 bus:AuditExemptWithAccountantsReport 2025-08-01 2026-03-31 12766946 bus:FilletedAccounts 2025-08-01 2026-03-31 12766946 bus:SmallCompaniesRegimeForAccounts 2025-08-01 2026-03-31 12766946 bus:RegisteredOffice 2025-08-01 2026-03-31 12766946 bus:Director1 2025-08-01 2026-03-31 12766946 bus:Director2 2025-08-01 2026-03-31 12766946 bus:OrdinaryShareClass1 2025-08-01 2026-03-31 12766946 bus:OrdinaryShareClass2 2025-08-01 2026-03-31 12766946 bus:OrdinaryShareClass3 2025-08-01 2026-03-31 12766946 bus:OrdinaryShareClass4 2025-08-01 2026-03-31 12766946 bus:PrivateLimitedCompanyLtd 2025-08-01 2026-03-31 12766946 core:FurnitureFittingsToolsEquipment 2025-08-01 2026-03-31 12766946 core:MotorVehicles 2025-08-01 2026-03-31 12766946 countries:EnglandWales 2025-08-01 2026-03-31 12766946 2025-07-31 12766946 core:FurnitureFittingsToolsEquipment 2025-07-31 12766946 core:MotorVehicles 2025-07-31 12766946 2024-08-01 2025-07-31 12766946 2025-07-31 12766946 bus:OrdinaryShareClass1 2025-07-31 12766946 bus:OrdinaryShareClass2 2025-07-31 12766946 bus:OrdinaryShareClass3 2025-07-31 12766946 bus:OrdinaryShareClass4 2025-07-31 12766946 core:CurrentFinancialInstruments 2025-07-31 12766946 core:CurrentFinancialInstruments core:WithinOneYear 2025-07-31 12766946 core:FurnitureFittingsToolsEquipment 2025-07-31 12766946 core:MotorVehicles 2025-07-31 12766946 bus:OrdinaryShareClass1 2024-08-01 2025-07-31 12766946 bus:OrdinaryShareClass2 2024-08-01 2025-07-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 12766946

Chapel Dental Laboratory Limited
Unaudited Filleted Financial Statements
for the Period from 1 August 2025 to 31 March 2026

Chapel Dental Laboratory Limited

Contents

Company Information | 1
Balance Sheet | 2
Notes to the Unaudited Financial Statements | 3 to 7

Chapel Dental Laboratory Limited

Company Information

Director | Mr Bruce Campbell Mr Sean Holland

Registered office | Unit 7 Chapel Mews Waterloo Street Hove, East Sussex East Sussex BN3 1AR

Accountants | Melrose Accountants 62 Florence Road Brighton East Sussex BN1 6DJ

Chapel Dental Laboratory Limited

(Registration number: 12766946)
Balance Sheet as at 31 March 2026

| Note | 2026 £ | 2025 £
Fixed assets |  |  |
Tangible assets | 4 | - | 5,547
Current assets |  |  |
Stocks | 5 | 11,393 | -
Debtors | 6 | 138,613 | 105,790
Cash at bank and in hand |  | 41,398 | 152,788
|  | 191,404 | 258,578
Creditors: Amounts falling due within one year | 7 | (43,893) | (62,125)
Net current assets |  | 147,511 | 196,453
Net assets |  | 147,511 | 202,000
Capital and reserves |  |  |
Called up share capital | 8 | 100 | 102
Retained earnings |  | 147,411 | 201,898
Shareholders' funds |  | 147,511 | 202,000

For the financial period ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and
• | The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 1 April 2026

......................................... Mr Bruce Campbell Director

Chapel Dental Laboratory Limited

Notes to the Unaudited Financial Statements for the Period from 1 August 2025 to 31 March 2026

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Unit 7 Chapel Mews
Waterloo Street
Hove, East Sussex
East Sussex
BN3 1AR

These financial statements were authorised for issue by the director on 1 April 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Chapel Dental Laboratory Limited

Notes to the Unaudited Financial Statements for the Period from 1 August 2025 to 31 March 2026

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.
The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Chapel Dental Laboratory Limited

Notes to the Unaudited Financial Statements for the Period from 1 August 2025 to 31 March 2026

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.
Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.
Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.
Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.
Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3 | Staff numbers

The average number of persons employed by the company (including the director) during the period, was 19 (2025 - 20).

Chapel Dental Laboratory Limited

Notes to the Unaudited Financial Statements for the Period from 1 August 2025 to 31 March 2026

4 | Tangible assets

| Furniture, fittings and equipment £ | Motor vehicles £ | Total £
Cost or valuation
At 1 August 2025 | 3,268 | 37,218 | 40,486
At 31 March 2026 | 3,268 | 37,218 | 40,486
Depreciation
At 1 August 2025 | 2,450 | 32,489 | 34,939
Charge for the period | 818 | 4,729 | 5,547
At 31 March 2026 | 3,268 | 37,218 | 40,486
Carrying amount
At 31 March 2026 | - | - | -
At 31 July 2025 | 818 | 4,729 | 5,547

5 | Stocks

| 2026 £ | 2025 £
Other inventories | 11,393 | -

6 | Debtors

Current | 2026 £ | 2025 £
Trade debtors | 118,568 | 100,598
Prepayments | 2,400 | -
Other debtors | 17,645 | 5,192
| 138,613 | 105,790

7 | Creditors

Creditors: amounts falling due within one year

Chapel Dental Laboratory Limited

Notes to the Unaudited Financial Statements for the Period from 1 August 2025 to 31 March 2026

| Note | 2026 £ | 2025 £
Due within one year |  |  |
Loans and borrowings |  | 1,127 | 3,381
Trade creditors |  | 6,419 | 6,889
Taxation and social security |  | 10,643 | 37,429
Accruals and deferred income |  | 19,433 | 4,000
Other creditors |  | 6,271 | 10,426
|  | 43,893 | 62,125

8 | Share capital

Allotted, called up and fully paid shares

| 2026 | 2025
| No. | £ | No. | £
Ordinary of £1 each | 90 | 90 | 90 | 90
A Ordinary of £1 each | 10 | 10 | 10 | 10
B Ordinary of £1 each | 1 | 1 | 1 | 1
C Ordinary of £1 each | 1 | 1 | 1 | 1
| 102 | 102 | 102 | 102

9 | Dividends

Interim dividends paid

|  | 2026 £ |  | 2025 £
Interim dividend of £Nil (2025 - £3,000.00) per each B Ordinary |  | - |  | 3,000
Interim dividend of £Nil (2025 - £30,640.00) per each C Ordinary |  | - |  | 30,640
|  | - |  | 33,640